153 related articles for article (PubMed ID: 32779831)
1. Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy.
Ricci KW; Chute C; Hammill AM; Dasgupta R; Patel M
Pediatr Blood Cancer; 2020 Oct; 67(10):e28277. PubMed ID: 32779831
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy and related complications following sclerotherapy of congenital venous malformations.
Swerdlin RF; Briones MA; Gill AE; Hawkins CM
Pediatr Blood Cancer; 2022 May; 69(5):e29610. PubMed ID: 35234344
[TBL] [Abstract][Full Text] [Related]
3. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography.
Mack JM; Pierce CD; Richter GT; Spray BJ; Nicholas R; Lewis PS; Becton D; Crary SE
Pediatr Blood Cancer; 2021 Feb; 68(2):e28824. PubMed ID: 33211399
[TBL] [Abstract][Full Text] [Related]
4. MRI phenotypes of localized intravascular coagulopathy in venous malformations.
Koo KS; Dowd CF; Mathes EF; Rosbe KW; Hoffman WY; Frieden IJ; Hess CP
Pediatr Radiol; 2015 Oct; 45(11):1690-5. PubMed ID: 26143286
[TBL] [Abstract][Full Text] [Related]
5. Association of localized intravascular coagulopathy with venous malformations.
Dompmartin A; Acher A; Thibon P; Tourbach S; Hermans C; Deneys V; Pocock B; Lequerrec A; Labbé D; Barrellier MT; Vanwijck R; Vikkula M; Boon LM
Arch Dermatol; 2008 Jul; 144(7):873-7. PubMed ID: 18645138
[TBL] [Abstract][Full Text] [Related]
6. D-dimer level correlation with treatment response in children with venous malformations.
Leung YC; Leung MW; Yam SD; Hung JW; Liu CS; Chung LY; Tang MY; Fung HS; Poon WL; Chao NS; Liu KK
J Pediatr Surg; 2018 Feb; 53(2):289-292. PubMed ID: 29221638
[TBL] [Abstract][Full Text] [Related]
7. Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Mack JM; Verkamp B; Richter GT; Nicholas R; Stewart K; Crary SE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27896. PubMed ID: 31250546
[TBL] [Abstract][Full Text] [Related]
8. Venous Malformation and Localized Intravascular Coagulopathy in Children.
Hung JW; Leung MW; Liu CS; Fung DH; Poon WL; Yam FS; Leung YC; Chung KL; Tang PM; Chao NS; Liu KK
Eur J Pediatr Surg; 2017 Apr; 27(2):181-184. PubMed ID: 27089461
[No Abstract] [Full Text] [Related]
9. Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
Lim CS; Evans N; Kaur I; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J
Vascular; 2021 Feb; 29(1):69-77. PubMed ID: 32605532
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Binet Q; Lambert C; Hermans C
Thromb Res; 2018 Aug; 168():114-120. PubMed ID: 30064682
[TBL] [Abstract][Full Text] [Related]
11. Extensive venous/lymphatic malformations causing life-threatening haematological complications.
Mazereeuw-Hautier J; Syed S; Leisner RI; Harper JI
Br J Dermatol; 2007 Sep; 157(3):558-63. PubMed ID: 17573883
[TBL] [Abstract][Full Text] [Related]
12. How we approach coagulopathy with vascular anomalies.
Mack JM; Crary SE
Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29353. PubMed ID: 36070211
[TBL] [Abstract][Full Text] [Related]
13. Venous malformations with severe localized intravascular coagulopathy treated with microwave ablation.
Tai MZ; Wang YP; Chen T; Li KL; Xu ZG; Ge CX; Qin ZP; Zheng JW
Vascular; 2022 Aug; 30(4):779-786. PubMed ID: 34144653
[TBL] [Abstract][Full Text] [Related]
14. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center.
Ali S; Weiss CR; Sinha A; Eng J; Mitchell SE
Phlebology; 2016 Oct; 31(9):603-9. PubMed ID: 27009607
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy complications of peripheral venous malformations.
Aronniemi J; Castrén E; Lappalainen K; Vuola P; Salminen P; Pitkäranta A; Pekkola J
Phlebology; 2016 Dec; 31(10):712-722. PubMed ID: 26494223
[TBL] [Abstract][Full Text] [Related]
16. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
17. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
[TBL] [Abstract][Full Text] [Related]
18. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
19. Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.
Serrano F; Bisdorff-Bresson A; Sroussi J; Aymard A; Wassef M; Civelli V; Boujlel S; Houdart E; Drouet L
J Med Vasc; 2020 Dec; 45(6):309-315. PubMed ID: 33248533
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Ardillon L; Lambert C; Eeckhoudt S; Boon LM; Hermans C
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):216-9. PubMed ID: 26484645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
